[内分泌眼科病的抗葡萄糖皮质激素的形式]
A F Brovkina1,2
1Russian Medical Academy of Continuous Professional Education, Moscow, Russia.
Vestnik oftalmologii
|December 28, 2024
概括
在内分泌眼科病 (EO) 中,葡萄糖皮质类药物耐药性很常见,影响多达20%的患者. 对NR3C1,CYP3A5和CYP3A4等关键基因的基因分析没有揭示影响这种抗性的一致模式.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
背景情况:
- 内分泌眼病 (EO),也称为格雷夫斯眼病或甲状腺眼病,是一种影响轨道组织的自身免疫性炎症性疾病.
- 它是Graves病的常见甲状腺外表现,患病率约为每10,000人中约有10例,特别是在50岁以上的人群中.
- 中度至非常严重的EO形式占4.9-10%的病例,通常呈现出眼外肌肉或轨道脂肪的参与.
研究的目的:
- 调查内分泌眼科医生 (EO) 患者对葡萄糖皮质类药物 (GC) 耐药性的遗传基础.
- 分析特定基因多态度在EO中的GC反应的分布和影响.
- 阐明这种自身免疫性疾病中GC抵抗的背后机制.
主要方法:
- 进行了临床观察和遗传分析.
- 研究了葡萄糖皮质体受体基因 (NR3C1),CYP3A5基因 (A6986G) 和CYP3A4基因 (C>T 内子6) 中的多态性.
- 评估了基因型分布和与GC反应的关联.
主要成果:
- 对于研究的多态标记物,在同卵性和异卵性基因型的分布中没有发现一致的模式.
- 分析的基因多态性 (CYP3A5,CYP3A4,NR3C1) 没有明确地影响EO患者的GC反应.
- 这些发现表明,EO中GC耐药性的机制无法通过检查的遗传变异来解释.
结论:
- NR3C1,CYP3A5和CYP3A4中的遗传变异似乎不是内分泌眼科病症中葡萄糖皮质类药物耐药性的主要驱动因素.
- 需要进一步的研究,以充分理解导致EO患者的GC不响应的复杂机制.
- 识别替代治疗点对于管理抗GC的甲状腺眼病病例至关重要.
相关概念视频
Glaucoma: Overview
465
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
465
Open Angle Glaucoma: Treatment
355
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
355
Angle Closure Glaucoma: Treatment
360
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
360
Adrenal Gland Disorders
1.2K
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.2K
Photoreceptors and Visual Pathways
5.4K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
5.4K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
83
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
83


